Office safety meeting ideas
Common Questions and Answers about Office safety meeting ideas
safety
Monday, May 23
The Food and Drug Administration (FDA) invites you to participate in a briefing to discuss two Direct Acting Antivirals (DAAs) for the treatment of hepatitis C, boceprevir and telaprevir, that were discussed at an April 27 - 28, 2011 meeting of the FDA Antiviral Drugs Advisory Committee. DAAs represent a significant addition to the treatment approach for many patients.
Thank you so much for attending our meeting on April 2. The turnout was wonderful! We hope that everyone got something out of the meeting. Thanks to the nurses and doctor who shared and all the great questions, we can each take something home.
Don't forget that the next meeting is July 9, 2009 and a Nutritionist will be joining us from Dr. Sherman's office.
Please feel free to post any questions and keep our great Q & A going from our last meeeting.
Former FDA Reviewer Speaks Out About Intimidation, Retaliation and Marginalizing of Safety
The Food and Drug Administration (FDA) is often accused of serving industry at the expense of consumers. But even FDA defenders are shocked by reports this week of an institutionalized FDA spying program on its own scientists, lawmakers, reporters and academics that included an enemies list of "actors" and collaborators.
FDA Teleconference - May 23, 2011
The Food and Drug Administration (FDA) invites you to participate in a teleconference briefing to discuss two Direct Acting Antivirals (DAAs) for the treatment of hepatitis C, boceprevir and telaprevir, that were discussed at an April 27 -28, 2011 meeting of the FDA Antiviral Drugs Advisory Committee. DAAs represent a significant addition to the treatment approach for many patients.
(Materials- Safety Pins and Jar). Pass around a jar full of baby safety pins. The one who guesses the closest wins a baby shower prize. A baby shower game favorite!
One of our visitors, Lynn, stated that she filled a clear plastic container (about 50 qt size with disposable diapers) all the same size (size 1) and had people guess how many diapers were in the container. Of course, container and contents go to mom since, as we all know, you can never have enough diapers.
I had heard his name and vice versa for a long time prior to meeting. He moved to the city I live in and then I heard his name even more. I felt like I knew a LOT about him prior to our meeting. I was at a big shebang of a party------- really fancy shmancy and I was all dolled up. At that party (probably in the cocktail line)---- I was introduced to my now husband. We kind of had an instant connection and from all the stories, we felt like we knew each other.
The data were presented in a late breaking oral presentation at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD).
JNJ-3989 is an investigational small interfering RNA (siRNA) that targets all hepatitis B virus (HBV) RNAs, thereby reducing levels of all viral proteins.
The company intends to submit a late-breaking abstract to present initial clinical data on ARO-HBV, if accepted, at the Liver Meeting® 2018, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD), being held in November. ARO-HBV leverages Arrowhead’s proprietary Targeted RNAi Molecule (TRiM™) technology.
Bruce Given, M.D.
Where did u all have your baby showers besides a hotel Meeting room? I need restaurant ideas!!??
s Office of Food Additive Safety, said irradiation made no significant nutritional or safety changes to spinach or lettuce.
The FDA's announcement of this decision comes hard on the heels of this summer's nationwide outbreak of Salmonella Saint Paul, which sickened hundreds. Of course, the source of this most recent outbreak was traced to a farm in Mexico… where they won't be irradiating the produce.
EDT
The primary goal of this virtual (online) meeting is to hear directly from patients about their perspectives on living with chronic hepatitis B and their experiences with treatments, to improve the development of new drugs in the research pipeline. The patient perspective is critical in helping the U.S. Food and Drug Administration (FDA) understand the context in which regulatory decisions are made for new drugs.
I like don't say baby. It goes on from beginning to the end and the mommy does not have to be involved.
Yes, bromley made a great point in choosing wisely when meeting with a specialist. Ive had 4 different ones untill i felt satisfied enough with what was happening to me and what he had to offer that the other cardiologists and ep didnt. Dont rush into one idea. Study as much as you can, get some good questions together, and if you feel as though he hasnt fullfilled those to the best of your knowledge, try getting a second opionon.
Recommended
